atomoxetine hydrochloride has been researched along with Stunted Growth in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; He, T; Wen, Y | 1 |
| Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E | 1 |
| Coghill, D; Graham, J | 1 |
2 review(s) available for atomoxetine hydrochloride and Stunted Growth
| Article | Year |
|---|---|
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Body Size; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Clonidine; Dextroamphetamine; Growth Disorders; Guanfacine; Heart Rate; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Propylamines; Psychoses, Substance-Induced; Seizures; Sleep Wake Disorders; Substance-Related Disorders; Suicide Prevention; Tic Disorders; Treatment Outcome | 2013 |
Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.
Topics: Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Central Nervous System Stimulants; Clinical Trials as Topic; Growth Disorders; Humans; Mental Disorders; Nervous System Diseases; Propylamines | 2008 |
2 other study(ies) available for atomoxetine hydrochloride and Stunted Growth
| Article | Year |
|---|---|
[Clinical and genetic analysis of a child with maternal uniparental disomy of chromosome 20].
Topics: Adult; Atomoxetine Hydrochloride; Child; Chromosomes, Human, Pair 20; DNA Copy Number Variations; Dwarfism; Female; Growth Disorders; Humans; Infant; Insulins; Intercellular Signaling Peptides and Proteins; Language Development Disorders; Male; Pregnancy; Retrospective Studies; Uniparental Disomy | 2023 |
ADHD update: new data on the risks of medication.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Death, Sudden, Cardiac; Drug Overdose; Growth Disorders; Humans; Methylphenidate; Propylamines | 2006 |